 |
Video: What is a Stock Split?
|
 |
| Surrozen, Inc. is a clinical-stage biotechnology company. Co. is engaged in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a range of organs and tissues. Co. is developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with a current focus on severe liver and eye diseases. Its two lead product candidates include SZN-043 and SZN-413. SZN-043 is the first development candidate using Surrozen's SWEETS technology. It is developing SZN-043 for severe liver diseases, initially focusing on alcohol-associated hepatitis. According to our SRZN split history records, Surrozen has had 1 split. | |
 |

Surrozen (SRZN) has 1 split in our SRZN split history database. The split for SRZN took place on December 14, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of SRZN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Surrozen conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SRZN split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Surrozen shares, starting with a $10,000 purchase of SRZN, presented on a split-history-adjusted basis factoring in the complete SRZN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/12/2021 |
|
| End date: |
12/10/2025 |
|
| Start price/share: |
$152.70 |
|
| End price/share: |
$23.95 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.32% |
|
| Average Annual Total Return: |
-31.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,568.01 |
|
| Years: |
4.91 |
|
|
 |
| Date |
Ratio |
| 12/14/2023 | 1 for 15 |
|
 |